Pronađeno: 1-2 / 2 radova

Autori: Pour Ludek

>> Filter: Samo Article i Review

Naslov Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study (Article)
Autori Pour Ludek  ...  Bila Jelena S  ...  (broj koautora 16) 
Info HAEMATOLOGICA, (2024), vol. 109 br. 3, str. 895-905
Projekat [NCT04649060]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy (Meeting Abstract)
Autori Mateos Maria-Victoria  Szarejko Monika  Bila Jelena S  Schjesvold Fredrik  Spicka Ivan  Maisnar Vladimir  Jurczyszyn Artur  Grudeva-Popova Zhanet  Hajek Roman  Usenko Hanna  Thuresson Marcus  Norin Stefan  Jarefors Sara  Richardson Paul  Pour Ludek 
Info CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S200-S201
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Ispis zapisa u formatu:TXT | BibTeX